Td Waterhouse Canada Inc. Ab Cellera Biologics Inc. Transaction History
Td Waterhouse Canada Inc.
- $16.1 Trillion
- Q4 2025
A detailed history of Td Waterhouse Canada Inc. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 22,412 shares of ABCL stock, worth $82,700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,412
Previous 24,538
8.66%
Holding current value
$82,700
Previous $146 Million
47.76%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ABCL
# of Institutions
160Shares Held
98.2MCall Options Held
1.26MPut Options Held
788K-
Baker Bros. Advisors LP New York, NY27.5MShares$102 Million1.13% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$49.3 Million0.01% of portfolio
-
Two Sigma Investments, LP New York, NY5.18MShares$19.1 Million0.04% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny4.8MShares$17.7 Million0.05% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$16.8 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.05B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...